Aurisco Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042S4
CNY
22.52
0.42 (1.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,465.82
1,252.70
1,000.45
796.51
715.37
576.48
569.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,465.82
1,252.70
1,000.45
796.51
715.37
576.48
569.45
Raw Material Cost
644.71
587.43
512.83
429.28
392.44
292.37
311.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
262.26
248.42
189.63
127.59
96.60
78.55
72.27
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.80
3.65
1.66
1.17
0.53
0.55
0.58
Selling and Distribution Expenses
285.96
259.79
164.58
122.87
91.08
91.45
84.57
Other Expenses
-14.77
-13.05
-8.43
-6.83
-5.77
-4.93
-5.17
Total Expenditure (Excl Depreciation)
1,061.99
968.83
784.38
612.59
522.91
413.62
417.49
Operating Profit (PBDIT) excl Other Income
403.8
283.9
216.1
183.9
192.5
162.89999999999998
152
Other Income
37.95
56.52
34.18
9.26
-6.23
45.96
11.33
Operating Profit (PBDIT)
512.15
414.38
313.21
247.95
217.67
235.98
171.92
Interest
16.80
3.65
1.66
1.17
0.53
0.55
0.58
Exceptional Items
2.25
0.00
0.00
0.00
0.62
-1.22
0.00
Gross Profit (PBDT)
821.11
665.27
487.61
367.23
322.94
284.11
257.67
Depreciation
90.21
81.65
70.80
54.77
32.02
27.90
7.16
Profit Before Tax
407.39
329.08
240.75
192.01
185.74
206.31
164.18
Tax
52.60
40.01
32.47
23.73
28.51
20.18
27.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
354.79
289.42
210.96
168.71
157.23
186.13
136.83
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
354.79
289.42
210.96
168.71
157.23
186.13
136.83
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.35
-2.69
-0.43
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
354.79
289.07
208.28
168.28
157.23
186.13
136.83
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,331.53
1,967.59
1,676.18
1,506.25
1,385.23
977.28
787.54
Earnings per share (EPS)
0.89
0.72
0.53
0.42
0.39
0.46
0.34
Diluted Earnings per share
0.89
0.72
0.53
0.42
0.39
0.46
0.34
Operating Profit Margin (Excl OI)
26.2%
22.05%
20.81%
23.09%
26.82%
28.12%
26.95%
Gross Profit Margin
33.95%
32.79%
31.14%
30.98%
30.44%
40.63%
30.09%
PAT Margin
24.2%
23.1%
21.09%
21.18%
21.98%
32.29%
24.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 17.01% vs 25.22% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 22.73% vs 38.79% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 32.50% vs 28.28% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 366.67% vs 111.76% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Aurisco Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,465.82
0
1,465.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,465.82
0
1,465.82
Raw Material Cost
644.71
0
644.71
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
262.26
0
262.26
Power Cost
0
0
0.00
Manufacturing Expenses
16.80
0
16.80
Selling and Distribution Expenses
285.96
0
285.96
Other Expenses
-14.77
0.00
-14.77
Total Expenditure (Excl Depreciation)
1,061.99
0
1,061.99
Operating Profit (PBDIT) excl Other Income
403.83
0.00
403.83
Other Income
37.95
0
37.95
Operating Profit (PBDIT)
512.15
0
512.15
Interest
16.80
0
16.80
Exceptional Items
2.25
0
2.25
Gross Profit (PBDT)
821.11
0
821.11
Depreciation
90.21
0
90.21
Profit Before Tax
407.39
0
407.39
Tax
52.60
0
52.60
Provisions and contingencies
0
0
0.00
Profit After Tax
354.79
0
354.79
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
354.79
0
354.79
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
354.79
0
354.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,331.53
0
2,331.53
Earnings per share (EPS)
0.89
0
0.89
Diluted Earnings per share
0.89
0
0.89
Operating Profit Margin (Excl OI)
26.20%
0%
0.00
26.20%
Gross Profit Margin
33.95%
0%
0.00
33.95%
PAT Margin
24.20%
0%
0.00
24.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 146.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 17.01% vs 25.22% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 35.48 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 22.73% vs 38.79% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.42 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 32.50% vs 28.28% in Dec 2023

Annual - Interest
Interest 1.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 366.67% vs 111.76% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.20%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023